| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2019 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 253,699 | $100.21 | $25,421,944.42 | -0.5% | |
| Aug 15, 2019 | TMO Thermo Fisher Scientific Inc. | Manzi Jim P52 | Director | Sell | 1,833 | $272.93 | $500,278.83 | -3.1% | |
| Aug 15, 2019 | RDNT Radnet, Inc. | Stolper Mark | Executive VP And CFO | Sell | 20,703 | $15.15 | $313,650.45 | -18.3% | |
| Aug 15, 2019 | PRPH Prophase Labs, Inc. | Barr Jason Michael | - | Buy | 8,500 | $2.05 | $17,425.00 | +39.6% | |
| Aug 15, 2019 | GH Guardant Health, Inc. | Wiley Michael J | Chief Legal Officer | Sell | 40,000 | $98.51 | $3,940,402.36 | -33.1% | |
| Aug 14, 2019 | BIO Bio-Rad Laboratories, Inc. | Crowley Michael60 | EVP, Gbl Commercial Operations | Sell | 325 | $320.00 | $104,000.00 | -9.5% | |
| Aug 14, 2019 | BIO Bio-Rad Laboratories, Inc. | Ernst Timothy S69 | EVP, General Counsel &Sec | Sell | 310 | $320.00 | $99,200.00 | -75.1% | |
| Aug 13, 2019 | GH Guardant Health, Inc. | Eltoukhy Helmy76 | Chief Executive Officer | Sell | 426,301 | $99.58 | $42,449,374.68 | -0.9% | |
| Aug 13, 2019 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 32,897 | $25.39 | $835,182.84 | -25.5% | |
| Aug 12, 2019 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 1,249 | $130.36 | $162,821.40 | -0.3% | |
| Aug 12, 2019 | RDNT Radnet, Inc. | Crues John V | Medical Director | Sell | 50,000 | $15.07 | $753,500.00 | -9.5% | |
| Aug 12, 2019 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 12,389 | $11.50 | $142,448.27 | -1.5% | |
| Aug 12, 2019 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Chairman And CEO | Sell | 8,000 | $25.28 | $202,236.80 | -6.6% | |
| Aug 9, 2019 | GH Guardant Health, Inc. | Lanman Richard B. | Chief Medical Officer | Sell | 63,075 | $105.25 | $6,638,675.13 | -11.0% | |
| Aug 9, 2019 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 15,000 | $26.38 | $395,680.50 | -7.3% | |
| Aug 8, 2019 | IQV Iqvia Holdings Inc. | Connaughton John | Director | Sell | 573,085 | $156.85 | $89,888,382.25 | -28.4% | |
| Aug 8, 2019 | IQV Iqvia Holdings Inc. | Tpg Group Holdings (sbs) Advisors, Inc.86 | Director | Sell | 2,616,028 | $156.85 | $410,323,991.80 | -30.7% | |
| Aug 6, 2019 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 9,683 | $89.75 | $869,080.36 | -38.2% | |
| Aug 6, 2019 | CDNA Caredx, Inc. | Maag Peter83 | Chief Executive Officer | Sell | 50,000 | $28.84 | $1,441,833.69 | -3.4% | |
| Aug 1, 2019 | MYGN Myriad Genetics Inc | Tobin Bernard | President Crescendo Bioscience | Sell | 11,712 | $40.00 | $468,480.00 | -7.4% | |
| Aug 1, 2019 | MYGN Myriad Genetics Inc | King Gary A. | Exec. VP International Ops | Sell | 60,000 | $43.49 | $2,609,329.00 | -12.9% | |
| Aug 1, 2019 | IQV Iqvia Holdings Inc. | Knightly Kevin C57 | See Remarks | Sell | 4,278 | $158.50 | $678,063.00 | -51.2% | |
| Aug 1, 2019 | MYGN Myriad Genetics Inc | Riggsbee Richard Bryan51 | Chief Financial Officer | Sell | 25,000 | $41.50 | $1,037,575.00 | -17.2% | |
| Aug 1, 2019 | MYGN Myriad Genetics Inc | Capone Mark Christopher | President &C.e.o. | Sell | 137,000 | $44.00 | $6,028,000.00 | -7.2% | |
| Jul 31, 2019 | EXAS Exact Sciences Corp | Doyle James Edward75 | Director | Sell | 2,808 | $117.93 | $331,147.44 | -7.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.